Filing Details
- Accession Number:
- 0001415889-24-019279
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-03 19:35:42
- Reporting Period:
- 2024-07-02
- Accepted Time:
- 2024-07-03 19:35:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1544227 | Tempest Therapeutics Inc. | TPST | Pharmaceutical Preparations (2834) | 451472564 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870373 | Samuel Whiting | C/O Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA 94005 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-02 | 4,672 | $2.13 | 9,573 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 3,000 shares acquired under the Issuer's stock purchase plan.
Billionaire Hedge Funds
